CTOs on the Move

Footprints to Recovery

www.footprintstorecovery.com

 
At Footprints to Recovery, our mission is to transform your life of addiction to a life of hope through inspiration, education, and support. We`re an individual focused and evidenced based addiction rehabilitation center, that emphasizes meaningful connections in recovery. We are conveniently located in Hamilton, NJ and Arlington Heights, IL.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Oak Hill Hospital

Oak Hill Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Oak Hill Hospital is based in Brooksville, FL. You can find more information on Oak Hill Hospital at www.oakhillhospital.com

DVM Resources

DVM Resources is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Heartland Health Region

Heartland Health Region is a Rosetown, SK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mela Sciences

At MELA Sciences, we design and develop innovative software-driven medical technologies for physician clinical use during the detection of skin cancers at the most curable and cost-effective stages. Our mission is to develop breakthrough medical technologies to improve skin cancer detection and achieve better outcomes for all. We envision a world in which our pioneering innovations will change the way patients think about skin cancer, while providing dermatologists and clinicians with new, effective, non-invasive tools for the earliest detection possible. MELA Sciences conducted the largest, positive prospective study ever done on the melanoma disease, and is the first and only medical technology company to receive both FDA Pre-Market Approval (PMA) for the U.S. and CE Marking certification for the European Union for a device of this nature. The company’s flagship product, MelaFind®, is intended to provide dermatologists with software-driven image analysis of clinically atypical pigmented skin lesions when they choose to obtain additional information to help decide whether to biopsy or not. The FDA has approved MELA Sciences’ MelaFind® Pre-Market Approval application for use in the United States and MELA Sciences has also been granted CE Mark approval for sale of MelaFind® in the European Union.

InsightRX

InsightRX is a healthcare technology company that has developed a platform for precision medicine and clinical analytics designed to individualize treatment at the point of care.